← Insider buys
ARPO

Aerpio Pharmaceuticals, Inc.

Novartis Bioventures Ltd sold $129K of Aerpio Pharmaceuticals, Inc.

10% owner

Sold$129,245
$0.99Price
130,594Shares
−2%Stake

What ARPO did after the filing

Prices for ARPO after this filing aren't in yet.

Traded Wed, Apr 3. Filed Fri, Apr 5, 1:14 PM ET, during the session. Not investment advice.